Sept 21 (Reuters) - Teva Pharmaceutical Industries Ltd:
* Press release- Teva files complaint against Mylan for infringement of four
copaxone-related patents
* Says patents expire in May 2014 and September 2015
* Says filed a complaint in the U.S. district court for the southern district
of New York
* Says no trial date is scheduled
* Says latest of copaxone patents expires in February 2020
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))
(For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
* Press release- Teva files complaint against Mylan for infringement of four
copaxone-related patents
* Says patents expire in May 2014 and September 2015
* Says filed a complaint in the U.S. district court for the southern district
of New York
* Says no trial date is scheduled
* Says latest of copaxone patents expires in February 2020
((Bangalore Equities Newsroom; +91 80 4135 5800; within U.S. +1 646 223 8780))
(For more news, please click here) COPYRIGHT Copyright Thomson Reuters 2010. All rights reserved. The copying, republication or redistribution of Reuters News Content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters.
© 2010 AFX News
